California State Teachers Retirement System (CalSTRS)’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-437
Closed -$9K 3345
2022
Q1
$9K Sell
437
-81
-16% -$2.8K ﹤0.01% 3194
2021
Q4
$31K Hold
518
﹤0.01% 3213
2021
Q3
$49K Sell
518
-810
-61% -$108K ﹤0.01% 3119
2021
Q2
$220K Sell
1,328
-3
-0.2% -$510 ﹤0.01% 2981
2021
Q1
$257K Buy
+1,331
New +$332K ﹤0.01% 2800

Other funds holding TLIS

California State Teachers Retirement System (CalSTRS)'s TLIS Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q2 2022, closing a stake of 437 shares — an estimated $9K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in TLIS in Q1 2021 and held it in 5 quarters. The position peaked at $257K in Q1 2021. 35 funds tracked by Wall St. Rank hold TLIS as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Talis Biomedical Corporation Common Stock position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 437 Talis Biomedical Corporation Common Stock shares in Q2 2022, an estimated $9K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Talis Biomedical Corporation Common Stock in Q1 2021 and held it in 5 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Talis Biomedical Corporation Common Stock position peaked at $257K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.